Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher to Redeem Senior Notes

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that it will redeem all of its outstanding 3.25 percent convertible senior subordinated notes due 2024.

The firm said that $329,229,000 million in aggregate principal amount of the notes was outstanding as of Feb. 25, 2011. The notes will be redeemed on March 30 at 100 percent of their principal amount plus accrued and unpaid interest to the redemption date, said Thermo Fisher.

Last week, the company sold $2.2 billion in senior notes, which will be used to pay for its acquisition of Dionex.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.